83 / 224
797
19. Skarzynski H, Lorens A, Matusiak M, Porowski M, Skarzynski
PH, James CJ. Partial deafness treatment with the nucleus
straight research array cochlear implant. Audiol Neurootol.
(2012). 17(2), 82-91.
20. Lehnhardt, E. Intracochlear placement of cochlear implant
electrodes in soft surgery technique. HNO, (1993), 41,
356–359.
21. Friedmann DR, Peng R, Fang Y, McMenomey SO, Roland JT,
Waltzman SB. Effects of loss of residual hearing on speech
performance with the CI422 and the Hybrid-L electrode.
Cochlear Implants Int. (2015), 16(5), 277-84
22. Fraysse B, Macias AR, Sterkers O, Burdo S, Ramsden R et
al. Residual hearing conservation and electroacoustic
stimulation with the Nucleus 24 Contour Advance cochlear
implant. Otol Neurotol (2006), 27, 624–633.
23. Obholzer RJ, Gibson WP. Cochlear function following
implantation with a full electrode array. Cochlear Implants
(2011), Int 12(1), 44-47.
24. Gantz BJ, Hansen MR, Turner CW, Oleson JJ, Reiss LA,
Parkinson AJ. Hybrid 10 clinical trial: preliminary results.
Audiol Neurootol (2009), 14(suppl 1), 32–38.
25. Roland JT Jr, Gantz BJ, Waltzman SB, Parkinson AJ. United
States multicenter clinical trial of the cochlear nucleus hybrid
implant system. Laryngoscope. (2016), 126(1), 175-81.
26. Skarzynski H, Lorens A, Matusiak M, Porowski M, Skarzynski
PH, James CJ. Cochlear implantation with the nucleus slim
straight electrode in subjects with residual low-frequency
hearing. Ear Hear. (2014). 35(2), e33-43
27. Skarzynski H, Matusiak M, Lorens A, Furmanek M, Pilka A,
Skarzynski PH. Preservation of cochlear structures and hearing
when using the Nucleus Slim Straight (CI422) electrode in
children. J Laryngol Otol. (2016). 130(4), 332-9.
28. Lenarz T. Cochlear Implantation with CI422 – Indication
for severe to profound deafness. Cochlear Manufacturer
Symposium, (2012), May 4 2012, Baltimore
29. Helbig S, Van de Heyning P, Kiefer J, Baumann U, Kleine-
Punte A, et al. Combined electric acoustic stimulation with
the PULSARCI (100) implant system using the FLEX (EAS)
electrode array. Acta Otolaryngol. (2011). 131(6), 585-95
30. Erixon E, Rask-Andersen H. Hearing and patient satisfaction
among 19 patients who received implants intended for hybrid
hearing: a two-year follow-up. Ear Hear. (2015), 36(5), e271-
8.
31. Tamir S, Ferrary E, Borel S, Sterkers O, Bozorg Grayeli A.
Hearing preservation after cochlear implantation using
deeply inserted flex atraumatic electrode arrays. Audiol
Neurootol. (2012). 17(5), 331-7.
32. Mick P, Amoodi H, Shipp D, Friesen L, Symons S et al. Hearing
preservation with full insertion of the FLEXsoft electrode. Otol
Neurotol. (2014), 35(1), e40-4
33. Santa Maria PL, Gluth MB, Yuan Y, Atlas MD, Blevins NH.
Hearing preservation surgery for cochlear implantation: a
meta-analysis. Otol Neurotol. (2014), 35(10), e256-69.
34. Kopelovich JC1, Reiss LA, Oleson JJ, Lundt ES, Gantz BJ, Hansen
MR. Risk factors for loss of ipsilateral residual hearing after
hybrid cochlear implantation. Otol Neurotol. (2014), 35(8),
1403-8.
35. Causon A, Verschuur C, Newman TA. A retrospective analysis of
the contribution of reported factors in cochlear implantation
on hearing preservation outcomes. Otol Neurotol. (2015).
36(7), 1137-45.
36. Kuthubutheen J, Smith L, Hwang E, Lin V. Preoperative
steroids for hearing preservation cochlear implantation: A
review. Cochlear Implants Int. (2016), 17(2), 63-74.
37. Rajan GP, Kuthubutheen J, Hedne N, Krishnaswamy J. The role
of preoperative, intratympanic glucocorticoids for hearing
preservation in cochlear implantation: a prospective clinical
study. Laryngoscope. (2012). 122(1), 190-5.
38. Sweeney AD, Carlson ML, Zuniga MG, Bennett ML, Wanna GB, et
al. Impact of perioperative oral steroid use on low-frequency
hearing preservation after cochlear implantation. Otol
Neurotol. (2015). 36(9), 1480-5.
39. Stathopoulos D, Chambers S, Enke YL, Timbol G, Risi F, et al.
Development of a safe dexamethasone-eluting electrode
array for cochlear implantation. Cochlear Implants Int.
(2014). 15(5), 254-63.
40. Lee MY, Lee JH, Lee HS, Choi JJ, Jang J, et al. Continuous topical
drug delivery using osmotic pump in animal cochlear implant
model: Continuous steroid delivery is effective for hearing
preservation. Acta Otolaryngol. (2015). 135(8), 791-8.
41. Simpson A, McDermott HJ, Dowell RC, Sucher C, Briggs RJ.
Comparison of two frequency-to-electrode maps for acoustic-
electric stimulation. Int J Audiol. (2009). 48(2), 63-73.
42. Fitzgerald MB1, Sagi E, Jackson M, Shapiro WH, Roland JT Jr,
et al. Reimplantation of hybrid cochlear implant users with
a full-length electrode after loss of residual hearing. Otol
Neurotol (2008). 29(2), 168–173.
[Estimulación electro-acústica una opción cuando audífonos no son suficiente - Herbert Mauch Diph-Ing. y col.]